Finance

Beta
Lists
ADIL:NASDAQ
Adial Pharmaceuticals Inc
$2.98
+37.96%
(+0.82) 1D
$2.86
-4.03% (-0.12)
After hours
Closed: Jun 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADIL...
Open
$2.28
High
$5.17
Low
$2.13
Mkt. cap
6.67M
Avg. vol.
154.10K
Volume
20.11M
52-wk high
$18.90
52-wk low
$1.31
EPS
-$9.93
Beta
1.46
Shares outstanding
2.14M
No. of employees
5
Open
$2.28
High
$5.17
Low
$2.13
Mkt. cap
6.67M
Avg. vol.
154.10K
Volume
20.11M
52-wk high
$18.90
52-wk low
$1.31
EPS
-$9.93
Beta
1.46
Shares outstanding
2.14M
No. of employees
5
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to ADIL in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for ADIL in the last 3 months.
Highest
Current $2.98
$8.00 (+168.46%)
Average
$8.00 (+168.46%)
Lowest
$8.00 (+168.46%)
News stories
From sources across the web
About Adial Pharmaceuticals Inc
CEO-
Employees5
Founded2010
HeadquartersCharlottesville, Virginia, United States
SectorPharmaceutical industry
Websiteadial.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
732.32K
521.07K
619.40K
432.53K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.15M
1.24M
1.27M
1.57M
Operating expense
1.88M
1.76M
1.89M
2.00M
Total operating expenses
1.88M
1.76M
1.89M
2.00M
Operating income
-1.88M
-1.76M
-1.89M
-2.00M
Other non operating income
-861.00
-513.00
-8.00
-
EBT including unusual items
-1.96M
-1.79M
-2.00M
-2.02M
EBT excluding unusual items
-1.96M
-1.79M
-2.00M
-2.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.96M
-1.79M
-2.00M
-2.02M
Net profit margin
-
-
-
-
Earnings per share
-4.50
-2.00
-11.48
-1.48
Interest and investment income
23.75K
47.86K
42.61K
47.06K
Interest expense
-
-
-
-
Net interest expenses
23.75K
47.86K
42.61K
47.06K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.88M
-1.76M
-1.89M
-2.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer